Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Joseph G. Toerner"'
Autor:
Thomas Salaets, Jonathan M. Davis, Michael D. Blum, Hidefumi Nakamura, Joseph G. Toerner, Susan McCune, Susan Tansey, Mary A Short, Ron Portman, Alexandra Mangili, Agnes Klein, Junko Sato, Barry Mangum, Laura Fabbri, Gerri Baer, Mark A. Turner, Isamu Hokuto, Karel Allegaert, Lynne Yao
Publikováno v:
Journal of Pediatrics, 219, 243-249. Mosby Inc.
ispartof: JOURNAL OF PEDIATRICS vol:219 pages:243-+ ispartof: location:United States status: published
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3ebc8ce042a32c4c797bb78ec806f39
https://doi.org/10.1016/j.jpeds.2019.09.060
https://doi.org/10.1016/j.jpeds.2019.09.060
Publikováno v:
Hepatology (Baltimore, Md.)References. 73(5)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ffd5c24fc21923fca9296f0c2cd72005
https://pubmed.ncbi.nlm.nih.gov/33340111
https://pubmed.ncbi.nlm.nih.gov/33340111
Autor:
Joseph G. Toerner, Edward Cox
One important component in determining the benefits and harms of medical interventions is the use of well-defined and reliable outcome assessments as endpoints in clinical trials. Improving endpoints can better define patient benefits, allowing more
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b6393fc592e2dfade0ee15a30fad1c3
https://europepmc.org/articles/PMC4741355/
https://europepmc.org/articles/PMC4741355/
Autor:
Dakshina Chilukuri, Owen McMaster, Kerry Snow, Kimberly Bergman, Joseph G. Toerner, Philip M Colangelo
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 61
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8bd22b4ad7d30c5b61aa556b7c917b17
https://pubmed.ncbi.nlm.nih.gov/26224770
https://pubmed.ncbi.nlm.nih.gov/26224770
Autor:
Joseph G. Toerner, Daniel B. Rubin
Publikováno v:
Clinical Infectious Diseases. 63:S37-S38
The Clinical Trials Transformation Initiative (CTTI), a public-private partnership comprised of representatives from academia, the pharmaceutical industry, and the federal government including the US Food and Drug Administration, formed a group worki
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::366f58da7c99df791828873add0bcc87
https://doi.org/10.1093/cid/ciw315
https://doi.org/10.1093/cid/ciw315
Publikováno v:
New England Journal of Medicine. 357:1154-1156
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d23d39724bed8ec8a266b8a9b8fb5d3e
https://doi.org/10.1056/nejmc071724
https://doi.org/10.1056/nejmc071724
Publikováno v:
Immunology and Allergy Clinics of North America. 17:195-205
Patients infected with the human immunodeficiency virus HIV are at high risk for infectious complications. Opportunistic pathogens cause significant morbidity and mortality in HIV-infected patients, and medications used for prophylaxis have gained wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b3b149bbad8ae6c5a90c5d6b0701819
https://doi.org/10.1016/s0889-8561(05)70301-5
https://doi.org/10.1016/s0889-8561(05)70301-5
Autor:
Stephen Mikita, Rosemary Tiernan, Deborah Collyar, Thomas L. Holland, Joseph G. Toerner, Jonas Santiago, Diane Bloom, Jamie N. Roberts, Jonathan McCall
Publikováno v:
BMJ Open
Objectives To explore patient, caregiver and physician perceptions and attitudes regarding the balance of benefit and risk in using antibacterial drugs developed through streamlined development processes. Design Semistructured focus groups and in-dep
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6de4e3f16cc38d5152a60dd34cf78744
https://doi.org/10.1136/bmjopen-2016-013561
https://doi.org/10.1136/bmjopen-2016-013561
Publikováno v:
Clinical Infectious Diseases. 55:1122-1123
Two important diseases in need of new antibacterial drugs are acute bacterial skin and skin structure infections (ABSSSIs) and community-acquired bacterial pneumonia (CABP). These are common infections in the United States, with millions of patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8f16010908dc324380b29a81f795f34
https://doi.org/10.1093/cid/cis567
https://doi.org/10.1093/cid/cis567
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 22(6)
We report a case of Guillain-Barre syndrome (GBS) associated with Rocky Mountain spotted fever (RMSF). The patient initially presented with fever, rash, and an altered mental status, and he responded to therapy with intravenous doxycycline; serologic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::855f49c1209403772619ec7dae2271c0
https://pubmed.ncbi.nlm.nih.gov/8783717
https://pubmed.ncbi.nlm.nih.gov/8783717